Case Reports
doi: 10.4088/jcp.v64n0518c.
Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder
- PMID: 12755669
- DOI: 10.4088/jcp.v64n0518c
Item in Clipboard
Case Reports
Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder
J Clin Psychiatry.
2003 May.
No abstract available
Similar articles
-
Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.Am J Psychiatry. 1999 Nov;156(11):1834-5. Am J Psychiatry. 1999. PMID: 10553756 No abstract available.
-
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.J Clin Psychiatry. 1999 Aug;60(8):524-7. doi: 10.4088/jcp.v60n0804. J Clin Psychiatry. 1999. PMID: 10485634 Clinical Trial.
-
Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.Psychosomatics. 2002 Jan-Feb;43(1):67-70. doi: 10.1176/appi.psy.43.1.67. Psychosomatics. 2002. PMID: 11927762 No abstract available.
-
Refractory obsessive-compulsive disorder: state-of-the-art treatment.J Clin Psychiatry. 2002;63 Suppl 6:20-9. J Clin Psychiatry. 2002. PMID: 12027116 Review.
-
[Neuroleptic malignant syndrome associated with olanzapine].Med Clin (Barc). 1999 Sep 4;113(6):239. Med Clin (Barc). 1999. PMID: 10472615 Review. Spanish. No abstract available.
Cited by
-
Interventions for obsessive compulsive symptoms in people with schizophrenia.Cochrane Database Syst Rev. 2005;(2):CD005236. doi: 10.1002/14651858.CD005236. Cochrane Database Syst Rev. 2005. PMID: 25267890 Free PMC article.
-
Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.Drugs R D. 2018 Sep;18(3):167-189. doi: 10.1007/s40268-018-0246-8. Drugs R D. 2018. PMID: 30171515 Free PMC article. Review.
-
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.CNS Drugs. 2004;18(14):989-1010. doi: 10.2165/00023210-200418140-00004. CNS Drugs. 2004. PMID: 15584769 Review.
-
Anxiety disorders and schizophrenia.Curr Psychiatry Rep. 2004 Aug;6(4):255-61. doi: 10.1007/s11920-004-0074-0. Curr Psychiatry Rep. 2004. PMID: 15260940 Review.
-
Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?Neurotherapeutics. 2009 Jan;6(1):86-93. doi: 10.1016/j.nurt.2008.10.034. Neurotherapeutics. 2009. PMID: 19110201 Free PMC article. Review.